IN2014CN03683A - - Google Patents

Download PDF

Info

Publication number
IN2014CN03683A
IN2014CN03683A IN3683CHN2014A IN2014CN03683A IN 2014CN03683 A IN2014CN03683 A IN 2014CN03683A IN 3683CHN2014 A IN3683CHN2014 A IN 3683CHN2014A IN 2014CN03683 A IN2014CN03683 A IN 2014CN03683A
Authority
IN
India
Prior art keywords
biological valve
artificial biological
pretreated
glutaraldehyde
groups
Prior art date
Application number
Other languages
English (en)
Inventor
Dakai Chen
Yu Li
Cong Tian
Yuan Fang
Jiaoming Dong
Cheng Chen
Xiulan Cheng
Guoming Chen
Chengjun Le
Qiyi Luo
Original Assignee
Shanghai Microport Medical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Microport Medical Group Co Ltd filed Critical Shanghai Microport Medical Group Co Ltd
Publication of IN2014CN03683A publication Critical patent/IN2014CN03683A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415—Manufacturing methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0029—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Manufacturing & Machinery (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
IN3683CHN2014 2011-11-01 2011-12-14 IN2014CN03683A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201110339534.3A CN102499993B (zh) 2011-11-01 2011-11-01 一种边缘刚性化人工生物瓣膜的制备方法
PCT/CN2011/083987 WO2013063842A1 (zh) 2011-11-01 2011-12-14 一种边缘刚性化人工生物瓣膜的制备方法

Publications (1)

Publication Number Publication Date
IN2014CN03683A true IN2014CN03683A (pt) 2015-09-04

Family

ID=46212166

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3683CHN2014 IN2014CN03683A (pt) 2011-11-01 2011-12-14

Country Status (7)

Country Link
EP (1) EP2774630B1 (pt)
CN (1) CN102499993B (pt)
AU (1) AU2011380375B2 (pt)
BR (1) BR112014010668B1 (pt)
ES (1) ES2639424T3 (pt)
IN (1) IN2014CN03683A (pt)
WO (1) WO2013063842A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
JP7006940B2 (ja) 2016-01-29 2022-01-24 ニオバスク ティアラ インコーポレイテッド 流出の閉塞を回避するための人工弁
CN113893064A (zh) 2016-11-21 2022-01-07 内奥瓦斯克迪亚拉公司 用于快速收回经导管心脏瓣膜递送系统的方法和系统
CN107007887B (zh) * 2017-02-27 2020-10-02 杭州启明医疗器械股份有限公司 一种交联人工生物瓣膜及其制备方法
WO2019036810A1 (en) 2017-08-25 2019-02-28 Neovasc Tiara Inc. TRANSCATHETER MITRAL VALVULE PROSTHESIS WITH SEQUENTIAL DEPLOYMENT
WO2019092736A1 (en) * 2017-11-13 2019-05-16 Meril Life Sciences Pvt Ltd Anti-calcification of a tissue
US11998447B2 (en) 2019-03-08 2024-06-04 Neovasc Tiara Inc. Retrievable prosthesis delivery system
CN113811265A (zh) 2019-04-01 2021-12-17 内奥瓦斯克迪亚拉公司 能够以可控的方式部署的假体瓣膜
US11491006B2 (en) 2019-04-10 2022-11-08 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
CN114025813B (zh) 2019-05-20 2024-05-14 内奥瓦斯克迪亚拉公司 具有止血机构的引入器
JP2022537559A (ja) 2019-06-20 2022-08-26 ニオバスク ティアラ インコーポレイテッド 薄型人工補綴僧帽弁
WO2021118964A1 (en) * 2019-12-09 2021-06-17 Edwards Lifesciences Corporation Bioprosthetic tissue preparation
CN111467574B (zh) * 2020-04-21 2021-01-26 四川大学 基于edc/nhs活化和重组人源胶原蛋白修饰的生物瓣膜材料及其制备方法
CN115998955A (zh) * 2022-12-09 2023-04-25 首都医科大学附属北京安贞医院 一种静脉桥的醛铬复合交联方法
CN117563049B (zh) * 2024-01-15 2024-05-03 北京佰仁医疗科技股份有限公司 用于后巩膜加固的眼科生物补片及其制备

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523810B1 (fr) * 1982-03-23 1988-11-25 Carpentier Alain Tissu biologique greffable et procede pour sa preparation
CA2196165C (en) * 1994-07-29 2004-06-08 Sophie Carpentier Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
EP0888142B1 (en) * 1996-03-04 2003-05-28 Edwards Lifesciences Corporation Nonpolymeric epoxy compounds for cross-linking biological tissue and bioprosthetic grafts prepared thereby
WO1997046266A1 (en) * 1996-06-03 1997-12-11 Gore Enterprise Holdings, Inc. Improved blood contact surfaces using extracellular matrix synthesized in vitro having bioactive species immobilized thereto
US6214054B1 (en) * 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
WO2001021228A1 (en) * 1999-09-22 2001-03-29 Baxter International Inc. Cardiac valve and method for preparing a biological tissue
US20040153145A1 (en) * 2002-11-26 2004-08-05 Clemson University Fixation method for bioprostheses
US20060217804A1 (en) * 2005-03-25 2006-09-28 Dove Jeffrey S Treatment of bioprosthetic tissues to mitigate post implantation calcification
US7579381B2 (en) * 2005-03-25 2009-08-25 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
CN101161293A (zh) * 2006-10-12 2008-04-16 胡盛寿 异种生物组织材料的抗钙化改性方法
CN102114269B (zh) * 2011-02-22 2013-12-11 上海微创医疗器械（集团）有限公司 一种异氰基封端型防钙化人工生物瓣及其制备方法

Also Published As

Publication number Publication date
CN102499993B (zh) 2014-01-15
ES2639424T3 (es) 2017-10-26
WO2013063842A1 (zh) 2013-05-10
EP2774630A4 (en) 2015-07-22
EP2774630A1 (en) 2014-09-10
BR112014010668A2 (pt) 2017-12-05
BR112014010668B1 (pt) 2019-04-02
AU2011380375B2 (en) 2015-09-17
AU2011380375A1 (en) 2014-05-29
CN102499993A (zh) 2012-06-20
EP2774630B1 (en) 2017-07-05

Similar Documents

Publication Publication Date Title
IN2014CN03683A (pt)
TW201129419A (en) Method for improving rejection of permeable membrane and permeable membrane
MX349658B (es) Metodo para la diferenciacion de las celulas madre pluripotentes en celulas de lecho vascular.
GB2485725A (en) Systems and methods for optimizing enterprise performance
WO2011022369A3 (en) Method for processing tissues
MX2013014307A (es) Metodo de tratamiento de celulas madre mesenquinales y su uso en el tratamiento de enfermedades asociadas a estres oxidativo.
AR060902A1 (es) Conservadores de bebidas
MY178152A (en) Isolation of stem cells from adipose tissue by ultrasonic cavitation, and methods of use
WO2010091049A3 (en) Diagnosis and treatment of cancer
EA201300780A1 (ru) Способ получения индуцированных плюрипотентных стволовых клеток и дифференцированных клеток
AR077403A1 (es) Un metodo para la produccion de una bebida alcoholica con un contenido de alcohol reducido
EA201690718A1 (ru) Способ обработки целлюлозосодержащей биомассы
MX2021000332A (es) Metodos para tratar rechazo mediado por anticuerpos en pacientes de trasplante de organos con inhibidor de c1-esterasa.
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
MX339403B (es) Uso de compuesto que libera peroxigeno libre de nitrogeno para reducir el crecimiento de microorganismos contaminantes en la fermentacion de etanol.
MX2013006838A (es) Composiciones efervescentes y uso de las mismas.
BRPI1009574A2 (pt) Método para reduzir a produção de co2 em um processo de fermentação para produzir um álcool, e, microorganismo modificado.
MX2014006192A (es) Metodos para la preparacion de hidrogeles usando enzimas de lipasas.
WO2012116077A3 (en) Methods for improving the appearance of aging skin using a composition comprising banyan tree, lotus, and clover serum fractions
CA2810119C (en) Clec14a inhibitors
WO2012116055A3 (en) Methods for improving the appearance of hyperpigmented skin using a synergistic composition comprising banyan tree, lotus, and clover serum fractions
ATE521249T1 (de) Verfahren zur herstellung fermentierter getränke
WO2012016229A3 (en) Oxytocin treatment to improve memory and modify blood glucose
MX2014013049A (es) Composiciones y metodos para sulfato de heparan como un biomarcador para rechazo de trasplante.
WO2011129607A3 (en) Method for increasing stem cell activity and stem cells produced thereby